Current Challenges in Cell and Gene Therapy

Regulatory

This live webinar shed light on the various aspects of Cell and Gene Therapy. Three industry experts shared their experience and knowledge on the regulatory, manufacturing and logistical challenges within the cell and gene therapy (CGT) space.

Presentations:

  • Updates on CGT Regulations in Australia by Dr George Vuckovic
  • Manufacturing and Regulatory Challenges in Allogenic Cell Therapies by Harsha Gupta
  • Logistical Challenges in CGT Clinical Trials by Manfred Seow

Key topics:

  • CGT regulatory pathways in Australia
  • Autologous, allogenic and gene cell therapies
  • Manufacturing challenges
  • CGT logistics

Speakers:

  • Dr George Vuckovic (Therapeutic Goods Administration, Australia)
  • Harsha Gupta (Cynata, Australia)
  • Manfred Seow (IQVIA, Singapore)

The presentation and recording from the webinar are available here:

Presentation

Recording

Click here for more information about our Asia-Pac events.

Related Education Resources.

All Resources

EAP video blog

Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning

Video

Members

Lessons Learned: Conducting COVID Clinical Trials and Building a Clinical Supplies Team During the Peak of the Pandemic

Topics: Conference, COVID-19

Executive Summary

Members

Video on ACE Requirements

Topics: Pharma Industry, Strategic Planning

Video

Members

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.